Abstract
Protein synthesis in dendrites is critical for long-term synaptic plasticity. Previous studies have identified an essential role of NMDA receptors in control of activity-dependent dendritic protein synthesis, but the contribution of NR2A- and NR2B-containing NMDA receptors, the two predominant subtypes of NMDA receptors in the forebrain, has not been determined. Using a pharmacological approach, we investigated the role of NR2A and NR2B subtypes in the regulation of NMDA-induced dendritic translation of a GFP reporter mRNA controlled by CaMKII untranslated regions (UTRs). We found that ifenprodil and Ro25-6981, two specific inhibitors of NR2B-containing NMDA receptors, did not affect dendritic GFP synthesis induced by NMDA. In contrast, NVP-AAM077, an antagonist that preferentially blocks the NR2A subtype, completely abolished NMDA-induced GFP synthesis in dendrites. Our results together suggest that NR2A but not NR2B subtypes are indispensable for NMDA receptor-dependent dendritic protein synthesis.
Original language | English (US) |
---|---|
Pages (from-to) | 252-256 |
Number of pages | 5 |
Journal | Neuropharmacology |
Volume | 53 |
Issue number | 2 |
DOIs | |
State | Published - Aug 2007 |
Keywords
- CaMKII
- Dendritic protein synthesis
- Hippocampal neurons
- NMDA receptors
- NR2A
- NR2B
ASJC Scopus subject areas
- Pharmacology
- Cellular and Molecular Neuroscience